Parents of adolescents with schizophrenia: get involved in a research study
Do you have a loved one between the ages of 13-17 who has been diagnosed with Schizophrenia or has symptoms of Schizophrenia? Are you interested in joining a clinical research study that may increase our understanding of the disease?
This study is designed to evaluate the safety and efficacy of an investigational drug, called brexpiprazole, for adolescent patients diagnosed with Schizophrenia. The study will compare this medication with an active control (ABILIFY® (aripiprazole)) and placebo. In order for your child to take part in the clinical research study, you will need to review the full checklist of criteria – found on the eligibility page. Some of the basic criteria that must be met are:
- Be 13-17 years old
- Have a diagnosis or symptoms of schizophrenia that has been confirmed by their doctor
- Do not have a diagnosis of autism, bipolar disorder, schizoaffective disorder, pervasive developmental disorder (PDD), OCD, or PTSD that has been the primary focus of treatment within 3 months of screening.
- Do not have a history of seizures, epilepsy, stroke, or head trauma.
Other requirements will be reviewed in detail with you by the Study Center staff, if your child meets the requirements above and attends a screening visit.